HALO logo
halo search icon
Jasper Therapeutics, Inc.

US$0.87

Price Change Indicator
0.0002 (0.023%)
Jasper Therapeutics, Inc.
JSPR · NAS

Jasper Therapeutics, Inc.

Start Trading JSPR for Free

US$0.87

Price Arrow0.0002 (0.023%)
21/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHALO Earnings MomentumRecent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Jasper Therapeutics, Inc. Overview

JSPR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About JSPR

icon

Website

Jasper Therapeutics, Inc.

icon

Telephone

icon

Address

Description

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.

JSPR Price Chart

Key Stats

Market Cap

US$24.42M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.62 - 7.19

Trade Value (12mth)

US$409,871.00

1 week

2.62%

1 month

-10.9%

YTD

-52.59%

1 year

-82.09%

All time high

188.80

Key Fundamentals

EPS 3 yr Growth

-61.70%

EBITDA Margin

0.00%

Operating Cashflow

-$77m

Free Cash Flow Return

-231.90%

ROIC

-227.80%

Interest Coverage

0.00

Quick Ratio

2.60

Other Data

Shares Outstanding (Fully Diluted)

29m

HALO Sector

Other Finance

Next Company Report Date

09-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

JSPR Announcements

Latest Announcements

DateAnnouncements
22 May 26
22 May 26
15 May 26
15 May 26
15 May 26

JSPR Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-6.18-4.89-3.95locklocklock
EPS (Fully Diluted)
 $locklocklocklock-6.18-4.89-3.95locklocklock
Growth
 %locklocklocklock40.220.919.1locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Jasper Therapeutics, Inc. (JSPR:NAS)?
Halo FAQ
The current share price of Jasper Therapeutics, Inc. (JSPR:NAS) is USD$0.87.
What is the 52-week high share price for Jasper Therapeutics, Inc. (JSPR:NAS)?
Halo FAQ
The 52-week high share price for Jasper Therapeutics, Inc. (JSPR:NAS) is USD$7.19.
What is the 52-week low share price for Jasper Therapeutics, Inc. (JSPR:NAS)?
Halo FAQ
The 52-week low share price for Jasper Therapeutics, Inc. (JSPR:NAS) is USD$0.62.
What is the dividend yield for Jasper Therapeutics, Inc. (JSPR:NAS)?
Halo FAQ
Jasper Therapeutics, Inc. (JSPR:NAS) does not pay a dividend.
What was Jasper Therapeutics, Inc. (JSPR:NAS) last dividend payment?
Halo FAQ
Jasper Therapeutics, Inc. (JSPR:NAS) does not pay a dividend.
What is the franking level for Jasper Therapeutics, Inc. (JSPR:NAS)?
Halo FAQ
Jasper Therapeutics, Inc. (JSPR:NAS) has a franking level of 0.00%.
In which sector is Jasper Therapeutics, Inc. (JSPR:NAS) classified?
Halo FAQ
Jasper Therapeutics, Inc. (JSPR:NAS) is classified in the Other Finance.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial